TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Fighting Flu Without Big Gun The Obama administration, worried that people could fall ill with swine flu before a vaccine is available, is urging Americans to adopt preventive actions. online.barrons.com |
Glaxo: Governments Up Vaccine Orders The U.K. drug maker said governments around the world have so far ordered 440 million doses of its swine-flu vaccine as they brace for a possible resurgence of the illness. online.barrons.com |
Auxilium Pharmaceuticals, Inc. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript Auxilium Pharmaceuticals, Inc. (AUXL)3Q09 (Qtr End 9/30/09) Earnings Call TranscriptOctober 28, 2009 10:00 ETComplete Story » seekingalpha.com |
Enzo signs marketing deal for cervical cancer test (AP) Enzo Biochem Inc. said Thursday it signed a marketing deal covering New York and New Jersey with Ikonisys Inc. for a molecular cervical cancer test. us.rd.yahoo.com |
Poniard Pharmaceuticals: A Rebound Is Overdue M.E. Garza submits: Colorectal cancer is the third most common form of cancer worldwide. Despite significant progress in its treatment over the past decade, colorectal cancer remains the second-leading cause of malignancy-related death in the United States.Currently, Oxaliplatin is typically administered with fluorouracil and leucovorin in a combination known as FOLFOX for the treatment of colorectal cancer. Oxaliplatin is marketed by Sanofi-Aventis (SNY) under the trademark Eloxatin, or by Medac GmbH under the trademark Oxaliplatin Medac. There are generic equivalents on the market now, but several big pharmaceutical companies, including Pfizer (PFE), are looking for a treatment that can replace FOLFOX (5fu/leucovorin + Oxaliplatin) in 1st line Colorectal Cancer.Complete Story » seekingalpha.com |